BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15716464)

  • 1. A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury.
    Fahrig T; Gerlach I; Horváth E
    Mol Pharmacol; 2005 May; 67(5):1544-55. PubMed ID: 15716464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
    Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats.
    Yune TY; Lee JY; Cui CM; Kim HC; Oh TH
    J Neurochem; 2009 Aug; 110(4):1276-87. PubMed ID: 19519665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
    Raghav SK; Gupta B; Shrivastava A; Das HR
    Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation.
    Wang T; Liu B; Zhang W; Wilson B; Hong JS
    J Pharmacol Exp Ther; 2004 Mar; 308(3):975-83. PubMed ID: 14718612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
    Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
    Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window.
    Nurmi A; Vartiainen N; Pihlaja R; Goldsteins G; Yrjänheikki J; Koistinaho J
    J Neurochem; 2004 Nov; 91(3):755-65. PubMed ID: 15485504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease.
    Bae N; Ahn T; Chung S; Oh MS; Ko H; Oh H; Park G; Yang HO
    J Ethnopharmacol; 2011 Mar; 134(2):313-22. PubMed ID: 21172413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
    Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.
    Zhang D; Anantharam V; Kanthasamy A; Kanthasamy AG
    J Pharmacol Exp Ther; 2007 Sep; 322(3):913-22. PubMed ID: 17565007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of novel small peptides in vitro and after brain injury.
    Faden AI; Movsesyan VA; Knoblach SM; Ahmed F; Cernak I
    Neuropharmacology; 2005 Sep; 49(3):410-24. PubMed ID: 15907950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
    Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
    Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
    Geng X; Tian X; Tu P; Pu X
    Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
    Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
    Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.